This report contains market size and forecasts of Recombinant Therapeutic Protein in global, including the following market information:
Global Recombinant Therapeutic Protein Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Recombinant Therapeutic Protein Market Sales, 2016-2021, 2022-2027, (MT)
Global top five Recombinant Therapeutic Protein companies in 2020 (%)
The global Recombinant Therapeutic Protein market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Therapeutic Protein manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Therapeutic Protein Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Recombinant Therapeutic Protein Market Segment Percentages, By Type, 2020 (%)
Recombinant Human Collage
Recombinant Human Serum Albumin
Global Recombinant Therapeutic Protein Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Recombinant Therapeutic Protein Market Segment Percentages, By Application, 2020 (%)
Medicine
Scientific Research
Others
Global Recombinant Therapeutic Protein Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Recombinant Therapeutic Protein Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Therapeutic Protein revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Recombinant Therapeutic Protein revenues share in global market, 2020 (%)
Key companies Recombinant Therapeutic Protein sales in global market, 2016-2021 (Estimated), (MT)
Key companies Recombinant Therapeutic Protein sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
Bristol-Myers Squibb
Celldex Therapeutics
Eli Liily
GlaxoSmithKline
Merck
Novartis
Regeneron Pharmaceuticals
Roche
Takeda
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Recombinant Therapeutic Protein Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Therapeutic Protein Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Therapeutic Protein Overall Market Size
2.1 Global Recombinant Therapeutic Protein Market Size: 2021 VS 2027
2.2 Global Recombinant Therapeutic Protein Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Recombinant Therapeutic Protein Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Recombinant Therapeutic Protein Players in Global Market
3.2 Top Global Recombinant Therapeutic Protein Companies Ranked by Revenue
3.3 Global Recombinant Therapeutic Protein Revenue by Companies
3.4 Global Recombinant Therapeutic Protein Sales by Companies
3.5 Global Recombinant Therapeutic Protein Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Recombinant Therapeutic Protein Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Recombinant Therapeutic Protein Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Therapeutic Protein Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Therapeutic Protein Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Therapeutic Protein Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Therapeutic Protein Market Size Markets, 2021 & 2027
4.1.2 Recombinant Human Collage
4.1.3 Recombinant Human Serum Albumin
4.2 By Type - Global Recombinant Therapeutic Protein Revenue & Forecasts
4.2.1 By Type - Global Recombinant Therapeutic Protein Revenue, 2016-2021
4.2.2 By Type - Global Recombinant Therapeutic Protein Revenue, 2022-2027
4.2.3 By Type - Global Recombinant Therapeutic Protein Revenue Market Share, 2016-2027
4.3 By Type - Global Recombinant Therapeutic Protein Sales & Forecasts
4.3.1 By Type - Global Recombinant Therapeutic Protein Sales, 2016-2021
4.3.2 By Type - Global Recombinant Therapeutic Protein Sales, 2022-2027
4.3.3 By Type - Global Recombinant Therapeutic Protein Sales Market Share, 2016-2027
4.4 By Type - Global Recombinant Therapeutic Protein Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Therapeutic Protein Market Size, 2021 & 2027
5.1.2 Medicine
5.1.3 Scientific Research
5.1.4 Others
5.2 By Application - Global Recombinant Therapeutic Protein Revenue & Forecasts
5.2.1 By Application - Global Recombinant Therapeutic Protein Revenue, 2016-2021
5.2.2 By Application - Global Recombinant Therapeutic Protein Revenue, 2022-2027
5.2.3 By Application - Global Recombinant Therapeutic Protein Revenue Market Share, 2016-2027
5.3 By Application - Global Recombinant Therapeutic Protein Sales & Forecasts
5.3.1 By Application - Global Recombinant Therapeutic Protein Sales, 2016-2021
5.3.2 By Application - Global Recombinant Therapeutic Protein Sales, 2022-2027
5.3.3 By Application - Global Recombinant Therapeutic Protein Sales Market Share, 2016-2027
5.4 By Application - Global Recombinant Therapeutic Protein Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Recombinant Therapeutic Protein Market Size, 2021 & 2027
6.2 By Region - Global Recombinant Therapeutic Protein Revenue & Forecasts
6.2.1 By Region - Global Recombinant Therapeutic Protein Revenue, 2016-2021
6.2.2 By Region - Global Recombinant Therapeutic Protein Revenue, 2022-2027
6.2.3 By Region - Global Recombinant Therapeutic Protein Revenue Market Share, 2016-2027
6.3 By Region - Global Recombinant Therapeutic Protein Sales & Forecasts
6.3.1 By Region - Global Recombinant Therapeutic Protein Sales, 2016-2021
6.3.2 By Region - Global Recombinant Therapeutic Protein Sales, 2022-2027
6.3.3 By Region - Global Recombinant Therapeutic Protein Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Recombinant Therapeutic Protein Revenue, 2016-2027
6.4.2 By Country - North America Recombinant Therapeutic Protein Sales, 2016-2027
6.4.3 US Recombinant Therapeutic Protein Market Size, 2016-2027
6.4.4 Canada Recombinant Therapeutic Protein Market Size, 2016-2027
6.4.5 Mexico Recombinant Therapeutic Protein Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Recombinant Therapeutic Protein Revenue, 2016-2027
6.5.2 By Country - Europe Recombinant Therapeutic Protein Sales, 2016-2027
6.5.3 Germany Recombinant Therapeutic Protein Market Size, 2016-2027
6.5.4 France Recombinant Therapeutic Protein Market Size, 2016-2027
6.5.5 U.K. Recombinant Therapeutic Protein Market Size, 2016-2027
6.5.6 Italy Recombinant Therapeutic Protein Market Size, 2016-2027
6.5.7 Russia Recombinant Therapeutic Protein Market Size, 2016-2027
6.5.8 Nordic Countries Recombinant Therapeutic Protein Market Size, 2016-2027
6.5.9 Benelux Recombinant Therapeutic Protein Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Recombinant Therapeutic Protein Revenue, 2016-2027
6.6.2 By Region - Asia Recombinant Therapeutic Protein Sales, 2016-2027
6.6.3 China Recombinant Therapeutic Protein Market Size, 2016-2027
6.6.4 Japan Recombinant Therapeutic Protein Market Size, 2016-2027
6.6.5 South Korea Recombinant Therapeutic Protein Market Size, 2016-2027
6.6.6 Southeast Asia Recombinant Therapeutic Protein Market Size, 2016-2027
6.6.7 India Recombinant Therapeutic Protein Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Recombinant Therapeutic Protein Revenue, 2016-2027
6.7.2 By Country - South America Recombinant Therapeutic Protein Sales, 2016-2027
6.7.3 Brazil Recombinant Therapeutic Protein Market Size, 2016-2027
6.7.4 Argentina Recombinant Therapeutic Protein Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Therapeutic Protein Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Recombinant Therapeutic Protein Sales, 2016-2027
6.8.3 Turkey Recombinant Therapeutic Protein Market Size, 2016-2027
6.8.4 Israel Recombinant Therapeutic Protein Market Size, 2016-2027
6.8.5 Saudi Arabia Recombinant Therapeutic Protein Market Size, 2016-2027
6.8.6 UAE Recombinant Therapeutic Protein Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Corporate Summary
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Recombinant Therapeutic Protein Major Product Offerings
7.1.4 Boehringer Ingelheim Recombinant Therapeutic Protein Sales and Revenue in Global (2016-2021)
7.1.5 Boehringer Ingelheim Key News
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporate Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Recombinant Therapeutic Protein Major Product Offerings
7.2.4 Bristol-Myers Squibb Recombinant Therapeutic Protein Sales and Revenue in Global (2016-2021)
7.2.5 Bristol-Myers Squibb Key News
7.3 Celldex Therapeutics
7.3.1 Celldex Therapeutics Corporate Summary
7.3.2 Celldex Therapeutics Business Overview
7.3.3 Celldex Therapeutics Recombinant Therapeutic Protein Major Product Offerings
7.3.4 Celldex Therapeutics Recombinant Therapeutic Protein Sales and Revenue in Global (2016-2021)
7.3.5 Celldex Therapeutics Key News
7.4 Eli Liily
7.4.1 Eli Liily Corporate Summary
7.4.2 Eli Liily Business Overview
7.4.3 Eli Liily Recombinant Therapeutic Protein Major Product Offerings
7.4.4 Eli Liily Recombinant Therapeutic Protein Sales and Revenue in Global (2016-2021)
7.4.5 Eli Liily Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Recombinant Therapeutic Protein Major Product Offerings
7.5.4 GlaxoSmithKline Recombinant Therapeutic Protein Sales and Revenue in Global (2016-2021)
7.5.5 GlaxoSmithKline Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Recombinant Therapeutic Protein Major Product Offerings
7.6.4 Merck Recombinant Therapeutic Protein Sales and Revenue in Global (2016-2021)
7.6.5 Merck Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Recombinant Therapeutic Protein Major Product Offerings
7.4.4 Novartis Recombinant Therapeutic Protein Sales and Revenue in Global (2016-2021)
7.7.5 Novartis Key News
7.8 Regeneron Pharmaceuticals
7.8.1 Regeneron Pharmaceuticals Corporate Summary
7.8.2 Regeneron Pharmaceuticals Business Overview
7.8.3 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Major Product Offerings
7.8.4 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales and Revenue in Global (2016-2021)
7.8.5 Regeneron Pharmaceuticals Key News
7.9 Roche
7.9.1 Roche Corporate Summary
7.9.2 Roche Business Overview
7.9.3 Roche Recombinant Therapeutic Protein Major Product Offerings
7.9.4 Roche Recombinant Therapeutic Protein Sales and Revenue in Global (2016-2021)
7.9.5 Roche Key News
7.10 Takeda
7.10.1 Takeda Corporate Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Recombinant Therapeutic Protein Major Product Offerings
7.10.4 Takeda Recombinant Therapeutic Protein Sales and Revenue in Global (2016-2021)
7.10.5 Takeda Key News
8 Global Recombinant Therapeutic Protein Production Capacity, Analysis
8.1 Global Recombinant Therapeutic Protein Production Capacity, 2016-2027
8.2 Recombinant Therapeutic Protein Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Therapeutic Protein Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Therapeutic Protein Supply Chain Analysis
10.1 Recombinant Therapeutic Protein Industry Value Chain
10.2 Recombinant Therapeutic Protein Upstream Market
10.3 Recombinant Therapeutic Protein Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Therapeutic Protein Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Recombinant Therapeutic Protein in Global Market
Table 2. Top Recombinant Therapeutic Protein Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Recombinant Therapeutic Protein Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Recombinant Therapeutic Protein Revenue Share by Companies, 2016-2021
Table 5. Global Recombinant Therapeutic Protein Sales by Companies, (MT), 2016-2021
Table 6. Global Recombinant Therapeutic Protein Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Recombinant Therapeutic Protein Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Recombinant Therapeutic Protein Product Type
Table 9. List of Global Tier 1 Recombinant Therapeutic Protein Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Therapeutic Protein Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type